A potential COVID-19 vaccine being developed by AstraZeneca and the University of Oxford was put on hold Tuesday after a participant in a large-scale trial developed a “potentially unexplained illness.”

Stat News first reported that the Stage 3 trial had been temporarily paused after a serious adverse reaction in a volunteer. The New York Times later added that the participant was a part of a Phase 2/3 trial of the drug in Britain who developed a serious inflammatory syndrome that affects the spinal cord. It’s unclear how long the trial will be on hold.

“As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee,” AstraZeneca said in a …continued .
[Source: Huffington Post]